Altimmune to participate in the h.c. wainwright 8th annual mash virtual conference

Gaithersburg, md., oct. 01, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that its chief executive officer, vipin garg, ph.d., and chief medical officer, scott harris, m.d., will participate in a fireside chat at the h.c. wainwright 8th annual mash virtual conference:
ALT Ratings Summary
ALT Quant Ranking